Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting

Keigan M. More; Karthik Tennankore

doi:10.1053/j.ackd.2021.02.007

Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting

Keigan M. More, Karthik Tennankore

Physics and Astronomy

Research output: Contribution to journal › Review article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	170-177
Number of pages	8
Journal	Advances in Chronic Kidney Disease
Volume	28
Issue number	2
DOIs	https://doi.org/10.1053/j.ackd.2021.02.007
Publication status	Published - Mar 2021

ASJC Scopus Subject Areas

Nephrology

Access to Document

10.1053/j.ackd.2021.02.007

Cite this

@article{b20501f073e14140b96dd0dd536d3f3b,

title = "Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting",

author = "More, {Keigan M.} and Karthik Tennankore",

note = "Funding Information: Financial Disclosure: The authors declare that they have no relevant financial interests. Support: K.T. has received investigator-initiated grant support from Astellas, Otsuka, and Baxter. He has conducted consulting work/Advisory Board work for Otsuka, Janssen, Baxter, and AstraZeneca. K.M. has no conflicts to declare. Funding Information: Support: K.T. has received investigator-initiated grant support from Astellas, Otsuka, and Baxter. He has conducted consulting work/Advisory Board work for Otsuka, Janssen, Baxter, and AstraZeneca. K.M. has no conflicts to declare. Publisher Copyright: {\textcopyright} 2021 National Kidney Foundation, Inc.",

year = "2021",

month = mar,

doi = "10.1053/j.ackd.2021.02.007",

language = "English",

volume = "28",

pages = "170--177",

journal = "Advances in Chronic Kidney Disease",

issn = "1548-5595",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting

AU - More, Keigan M.

AU - Tennankore, Karthik

N1 - Funding Information: Financial Disclosure: The authors declare that they have no relevant financial interests. Support: K.T. has received investigator-initiated grant support from Astellas, Otsuka, and Baxter. He has conducted consulting work/Advisory Board work for Otsuka, Janssen, Baxter, and AstraZeneca. K.M. has no conflicts to declare. Funding Information: Support: K.T. has received investigator-initiated grant support from Astellas, Otsuka, and Baxter. He has conducted consulting work/Advisory Board work for Otsuka, Janssen, Baxter, and AstraZeneca. K.M. has no conflicts to declare. Publisher Copyright: © 2021 National Kidney Foundation, Inc.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85118133169&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118133169&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2021.02.007

DO - 10.1053/j.ackd.2021.02.007

M3 - Review article

C2 - 34717864

AN - SCOPUS:85118133169

SN - 1548-5595

VL - 28

SP - 170

EP - 177

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

IS - 2

ER -

Quality Assurance and Preventing Serious Adverse Events in the Home Hemodialysis Setting

ASJC Scopus Subject Areas

Access to Document

Other files and links

Fingerprint

Cite this